Drug

AZD4547 clinical trials

Also written AZD4547 and ABSK091.

studies test it: 17
open now: 1
in phase 3: 1
first study started: 2009

Keep track of what changes. Save the AZD4547 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

17 studies that test it; most in 2014 (4)

Studies that test AZD4547, by start year
Year	Studies
2009	1
2010	2
2011	1
2012	1
2014	4
2015	3
2016	2
2020	1
2021	1
2022	1

By phase

A phase 1/2 study counts in both.

Phase 1: 8
Phase 2: 13
Phase 3: 1

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Non-Small-Cell Lung: 3
Carcinoma: 3
Breast Neoplasms: 2
Neoplasms: 2
Lymphoma: 1
Stomach Neoplasms: 1

Who runs them

Industry 8 · Other 9

AstraZeneca (5) · Abbisko Therapeutics Co, Ltd (3) · National Cancer Institute (NCI) (2) · UNICANCER (2) · University of Birmingham (1) · ECOG-ACRIN Cancer Research Group (1) · SWOG Cancer Research Network (1) · Assistance Publique - Hôpitaux de Paris (1)

Often tested with

Tested in the same studies.

Capivasertib (4) · Durvalumab (4) · Vistusertib (4) · AZD 6244 (4) · Olaparib (3) · Docetaxel (3) · Adavosertib (2) · Crizotinib (2)

Studies

Open first, then newest update. How each study uses AZD4547 is read from its arms, and is right about nine times in ten.

AZD4547 clinical trials

How studies write it

Name

Development codes

Other names